Published in Eur J Pharm Sci on December 01, 1999
Parts per Million Powder X-ray Diffraction. Anal Chem (2015) 0.75
The size and shape of human and bovine antithrombin III. Eur J Biochem (1977) 1.61
Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech (2000) 1.45
Isolation and identification of Taylorella asinigenitalis from the genital tract of a stallion, first case of a natural infection. Vet Microbiol (2006) 1.45
Characterization of a diltiazem-lambda carrageenan complex. Int J Pharm (2000) 1.14
Studies on direct compression of tablets. IV. The effect of particle size on the mechanical strength of tablets. Acta Pharm Suec (1982) 1.10
On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. J Control Release (1998) 1.07
Disintegrating force as a new formulation parameter. J Pharm Sci (1984) 1.05
Studies on direct compression of tablets. XIX. The effect of particle size and shape on the mechanical strength of sodium bicarbonate tablets. Acta Pharm Suec (1988) 0.98
Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol (2005) 0.95
Assessing tablet bond types from structural features that affect tablet tensile strength. Pharm Res (2001) 0.94
Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab. Ann Rheum Dis (2006) 0.93
Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease. Acta Neurol Scand (1998) 0.92
Cellulose powder from Cladophora sp. algae. J Mol Recognit (1998) 0.90
Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements. Eur J Pharm Sci (2000) 0.90
Influence of mucin type on polymer-mucin rheological interactions. Biomaterials (1995) 0.89
Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis. Eur J Pharm Biopharm (2009) 0.89
Radial and axial tensile strength and strength variability of paracetamol tablets. Acta Pharm Suec (1984) 0.87
Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. J Pharm Sci (1992) 0.87
Measurement of axial and radial tensile strength of tablets and their relation to capping. Acta Pharm Suec (1978) 0.86
Thiamin contents of cerebrospinal fluid, plasma and erythrocytes in cerebellar ataxias. Eur Neurol (1992) 0.85
A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm Dev Technol (1999) 0.85
The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug. Eur J Pharm Sci (2001) 0.85
Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex. Pharm Dev Technol (2004) 0.84
Evaluation of strength-enhancing factors of a ductile binder in direct compression of sodium bicarbonate and calcium carbonate powders. Eur J Pharm Sci (2000) 0.84
Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. Farmaco (1998) 0.84
Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers. Acta Neurol Scand (2012) 0.83
Studies on direct compression of tablets. III. The effect on tablet strength of changes in particle shape and texture obtained by milling. Acta Pharm Suec (1982) 0.83
The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci (1999) 0.82
The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs. Int J Pharm (1999) 0.82
Drug release and washability of mucoadhesive gels based on sodium carboxymethylcellulose and polyacrylic acid. Pharm Dev Technol (1999) 0.82
Effective dosage of antacid products. Farmaco Prat (1980) 0.82
Effective surface area and activity of antacid preparations. Farmaco Prat (1985) 0.82
Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease. Eur J Clin Pharmacol (1993) 0.81
Characterization of chitosan hydrochloride--mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio. Eur J Pharm Sci (2001) 0.81
A novel tablet-based 13C urea breath test for Helicobacter pylori with enhanced performance during acid suppression therapy. Scand J Gastroenterol (1999) 0.81
The use of ordered mixtures for improving the dissolution rate of low solubility compounds. J Pharm Pharmacol (1986) 0.81
Bile salt malabsorption in the radiation syndrome. Acta Radiol Oncol Radiat Phys Biol (1978) 0.80
Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011? Horm Cancer (2011) 0.80
Rheological and mechanical properties of pharmaceutical gels. Part II: Medicated systems: relevance to hydration properties and drug release. Boll Chim Farm (2001) 0.79
Studies on direct compression of tablets. VI. Evaluation of methods for the estimation of particle fragmentation during compaction. Acta Pharm Suec (1982) 0.79
Structural studies of the O-specific side-chains of the Escherichia coli O2 lipopolysaccharide. Carbohydr Res (1987) 0.79
Effect of a low-fat diet on bile salt excretion and diarrhoea in the gastrointestinal radiation syndrome. Acta Radiol Oncol Radiat Phys Biol (1979) 0.79
"Sponge-like" dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Int J Pharm (2012) 0.78
Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design. Pharm Dev Technol (1996) 0.78
Myometrial blood flow studies in carcinoma of the corpus uteri. A preliminary report on the clearance method using xenon 133. Acta Radiol Ther Phys Biol (1969) 0.78
Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan. J Pharm Pharmacol (2006) 0.78
Porous cellulose matrices containing lipophilic release modifiers--a potential oral extended-release system. Int J Pharm (1999) 0.77
Use of tablet tensile strength adjusted for surface area and mean interparticulate distance to evaluate dominating bonding mechanisms. Drug Dev Ind Pharm (1999) 0.77
Relationships between EEG and clinical characteristics in major depressive disorder. Acta Psychiatr Scand (1986) 0.77
Rheological properties and diffusion dissolution behaviour of hydrophilic polymers. Boll Chim Farm (1989) 0.76
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up. Eur J Nucl Med Mol Imaging (2015) 0.76
Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol (2005) 0.75
Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol. Eur J Drug Metab Pharmacokinet (1997) 0.75
[Disintegrating power of tablets]. Farmaco Prat (1980) 0.75
Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers. Eur J Surg Oncol (2013) 0.75
Comparison of permeametry and photometry for the measurement of surface area of powders. Acta Pharm Suec (1977) 0.75
Comparison between the ring gap sizer and dry sieving. Acta Pharm Suec (1977) 0.75
Drug permeation through directly compressed polymeric barriers. Farmaco Prat (1985) 0.75
Studies on the physical properties of tablets and tablet excipients. I. Adsorption of drugs to cellulose used in tablets. Acta Pharm Suec (1978) 0.75
Quantitative infrared analysis of the interaction between trimethoprim and sulfamethoxazole in solid phase. Farmaco Prat (1981) 0.75
Palmitoyl Glycol Chitosan Micelles for Corneal Delivery of Cyclosporine. J Biomed Nanotechnol (2016) 0.75
The compactability of polymers for drug delivery systems. Farmaco Prat (1983) 0.75
Studies on direct compression of tablets. I. The effect of particle size in mixing finely divided powders with granules. Acta Pharm Suec (1980) 0.75
Drug interactions and physical properties in trimethoprim-sulfamethoxazole suspensions. Farmaco Prat (1980) 0.75
[Biopharmaceutics and pharmacokinetics. 5. Distribution]. Boll Chim Farm (1993) 0.75
A study on the electrokinetic properties of some chemotherapeutic drug suspensions. Farmaco Prat (1979) 0.75
Antacid tablets strength and neutralization rate. Pharm Acta Helv (1983) 0.75
Opportunities offered by chitosan-based nanotechnology in mucosal/skin drug delivery. Curr Top Med Chem (2015) 0.75
The relevance of viscous behaviour to stress/displacement relationship in pharmaceutical powders compression. Farmaco Prat (1978) 0.75
[Biopharmaceutics and pharmacokinetics. 7. Excretion]. Boll Chim Farm (1994) 0.75
Model-based interpretation of creep profiles for the assessment of polymer-mucin interaction. Pharm Res (1999) 0.75
Sequential atomic force microscopy imaging of a spontaneous nanoencapsulation process. Int J Pharm (2002) 0.75
[Comments on the metabolism of folic acid]. Lakartidningen (1967) 0.75
[Biopharmaceutics and pharmacokinetics. 6. Metabolism]. Boll Chim Farm (1994) 0.75
[Biopharmaceutics and pharmacokinetics. 10. Integration of the two concepts: A. Monocompartmental models]. Boll Chim Farm (1994) 0.75
Swelling-restricted minimatrices for controlled release of drugs. Preliminary in-vivo studies. Boll Chim Farm (1989) 0.75
Zimelidine vs maprotiline in depressed outpatients. A preliminary report. Acta Psychiatr Scand Suppl (1981) 0.75
Sustained release nitrofurantoin tablets by direct compression. Farmaco Prat (1979) 0.75
Measurement of the minimum dimension of particles by a ring gap sizer. Acta Pharm Suec (1977) 0.75
Rheological and mechanical properties of pharmaceutical gels. Part I: Non-medicated systems. Boll Chim Farm (2001) 0.75
The effect of formulation factors on the solid state interaction between trimethoprim and sulfamethoxazole in compressed tablets. Farmaco Prat (1983) 0.75
A computer-aided simulation approach in the development of a prolonged release formulation. Boll Chim Farm (1991) 0.75
[Description of therapeutic systems using transmucosal absorption]. Boll Chim Farm (1984) 0.75
Press-coated, zero order drug delivery systems. Farmaco Prat (1984) 0.75
[Bioadhesives: rationale, state of the art and therapeutic potential]. Boll Chim Farm (1995) 0.75
[Extraneous particle contamination in injectable solutions. Proposed Italian standard]. Farmaco Prat (1981) 0.75
A new approach to tensile strength measurement of tablets. Acta Pharm Suec (1977) 0.75
Simulation of the disintegration process of pharmaceutical tablets. Pharm Acta Helv (1988) 0.75
In vitro absorption studies on trimethoprim and sulfamethoxazole note II. Pharm Acta Helv (1983) 0.75
In vitro absorption studies on trimethoprim and sulfamethoxazole. Note I. Pharm Acta Helv (1982) 0.75
Drug content uniformity of directly compressed tablets in relation to the physical characteristics of diluents. Boll Chim Farm (1978) 0.75